Cell Reports (Mar 2017)

Circulating NOD1 Activators and Hematopoietic NOD1 Contribute to Metabolic Inflammation and Insulin Resistance

  • Kenny L. Chan,
  • Theresa H. Tam,
  • Parastoo Boroumand,
  • David Prescott,
  • Sheila R. Costford,
  • Nichole K. Escalante,
  • Noah Fine,
  • YuShan Tu,
  • Susan J. Robertson,
  • Dilshaayee Prabaharan,
  • Zhi Liu,
  • Philip J. Bilan,
  • Michael W. Salter,
  • Michael Glogauer,
  • Stephen E. Girardin,
  • Dana J. Philpott,
  • Amira Klip

DOI
https://doi.org/10.1016/j.celrep.2017.02.027
Journal volume & issue
Vol. 18, no. 10
pp. 2415 – 2426

Abstract

Read online

Insulin resistance is a chronic inflammatory condition accompanying obesity or high fat diets that leads to type 2 diabetes. It is hypothesized that lipids and gut bacterial compounds in particular contribute to metabolic inflammation by activating the immune system; however, the receptors detecting these “instigators” of inflammation remain largely undefined. Here, we show that circulating activators of NOD1, a receptor for bacterial peptidoglycan, increase with high fat feeding in mice, suggesting that NOD1 could be a critical sensor leading to metabolic inflammation. Hematopoietic depletion of NOD1 did not prevent weight gain but protected chimeric mice against diet-induced glucose and insulin intolerance. Mechanistically, while macrophage infiltration of adipose tissue persisted, notably these cells were less pro-inflammatory, had lower CXCL1 production, and consequently, lower neutrophil chemoattraction into the tissue. These findings reveal macrophage NOD1 as a cell-specific target to combat diet-induced inflammation past the step of macrophage infiltration, leading to insulin resistance.

Keywords